In Vitro Cross-Resistance Profile of Nucleoside Reverse Transcriptase Inhibitor (NRTI) BMS-986001 against Known NRTI Resistance Mutations

समान संसाधन

• Activity of the HIV-1 Attachment Inhibitor BMS-626529, the Active Component of the Prodrug BMS-663068, against CD4-Independent Viruses and HIV-1 Envelopes Resistant to Other Entry Inhibitors
  द्वारा: Li, Zhufang, और अन्य
  प्रकाशित: (2013)
• The Nucleoside Analog BMS-986001 Shows Greater In Vitro Activity against HIV-2 than against HIV-1
  द्वारा: Smith, Robert A., और अन्य
  प्रकाशित: (2015)
• BMS-986001, an HIV Nucleoside Reverse Transcriptase Inhibitor, Does Not Degrade Mitochondrial DNA in Long-Term Primary Cultures of Cells Isolated from Human Kidney, Muscle, and Adipose Tissue
  द्वारा: Wang, Faye, और अन्य
  प्रकाशित: (2013)
• Identification and Characterization of BMS-955176, a Second-Generation HIV-1 Maturation Inhibitor with Improved Potency, Antiviral Spectrum, and Gag Polymorphic Coverage
  द्वारा: Nowicka-Sans, Beata, और अन्य
  प्रकाशित: (2016)
• Abacavir versus other nucleoside reverse transcriptase inhibitor (NRTI) backbone therapies for treatment of HIV infection
  द्वारा: Cruciani, Mario, और अन्य
  प्रकाशित: (2018)